CIPMOLNU 200 Capsule 40's
Key Information
Generic Name
Generic Name Molnupiravir 200 mg
Manufacturer
Cipla Ltd
Variant
40 Capsule(s) in a Strip
Country of Origin
India
Detailed Information
Introduction
INTRODUCTIONCIPMOLNU 200 contains Molnupiravir which belongs to the group of medicines called Antiviral drugs. It is used in adults to manage mild to moderate COVID-19 disease who are at risk of developing severe illness. COVID-19 is a highly infectious and spreading respiratory disease caused by the SARS-CoV-2 virus. It is characterized by symptoms such as fever, chills, sore throat, cough, shortness of breath, weakness, body aches, headache, loss of taste or smell, runny nose, diarrhoea, nausea, and vomiting. CIPMOLNU 200 is not recommended for use in patients who are allergic to molnupiravir. It should be used with caution in patients who are scheduled to undergo liver transplant surgery and in patients with chronic liver and kidney disease. [GNKEYWORD] is not recommended for use in pregnant and breastfeeding women. Also, it is not recommended for use in children and adolescents (below 18 years of age) and it should be used caution in elderly patients (aged above 60 years). Consult your doctor before taking this medicine. The common
Uses
OF CIPMOLNU 200 Manages mild to moderate COVID-19 disease
How It Works
CIPMOLNU 200 reduces the risk of developing severe illness in mild to moderate COVID-19 disease, where molnupiravir works by converting into a metabolite that gets incorporated into the genetic material of the new virus that results in impaired ability of the virus to multiply/replicate its own copies leading to reduced viral load in the lungs thus preventing the risk of developing severe illness in the affected individuals.
Directions for Use
Take CIPMOLNU 200 as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Side Effects
CIPMOLNU 200 are diarrhoea, nausea, dizziness, and headache. Contact your doctor if any of the symptom worsens. USES OF CIPMOLNU 200 Manages mild to moderate COVID-19 disease HOW CIPMOLNU 200 WORKSCIPMOLNU 200 reduces the risk of developing severe illness in mild to moderate COVID-19 disease, where molnupiravir works by converting into a metabolite that gets incorporated into the genetic material of the new virus that results in impaired ability of the virus to multiply/replicate its own copies leading to reduced viral load in the lungs thus preventing the risk of developing severe illness in the affected individuals. DIRECTIONS FOR USETake CIPMOLNU 200 as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition. SIDE EFFECTS OF CIPMOLNU 200COMMON diarrhoea nausea dizziness headache UNCOMMON vomiting rash hives (red, itchy skin)
Warnings & Precautions
& PRECAUTIONSPREGNANCYCIPMOLNU 200 is not recommended for use during pregnancy. Women with childbearing potential should use effective birth control while taking CIPMOLNU 200. Consult your doctor before taking this medicine. BREASTFEEDINGCIPMOLNU 200 is not recommended for use in breastfeeding women. Consult your doctor before taking CIPMOLNU 200. DRIVING AND USING MACHINESConsult your doctor if CIPMOLNU 200 affects your ability to drive or operative machines. KIDNEYCIPMOLNU 200 should be used with caution in patients with kidney problems such as chronic kidney disease. Consult your doctor before taking CIPMOLNU 200. LIVERCIPMOLNU 200 should be used with caution in patients with chronic liver disease and in patients planned for liver transplant surgery. Consult your doctor before taking CIPMOLNU 200. ALLERGYDo not take CIPMOLNU 200 if you are allergic to molnupiravir or any other ingredients of this medicine. Consult your doctor before taking CIPMOLNU 200. OTHERSUse in Paediatrics: CIPMOLNU 200 is not recommended for use in children and adolescents (below 18 years of age). Consult child’s doctor for advice. Use in Geriatrics: CIPMOLNU 200 should be used with caution in elderly patients (aged above 60 years). Consult your doctor before taking CIPMOLNU 200.
Drug Interactions
SA. Drug-Drug Interactions: Before taking CIPMOLNU 200, inform your doctor if you are taking any medicines including prescription or non-prescription medicines and herbals or vitamin supplements. Overdosage: If you or anyone else accidentally takes too much of CIPMOLNU 200, consult your doctor immediately or visit the nearby hospital if you experience any unusual symptoms. SYNOPSIS Drug : Molnupiravir Pharmacological Category : Antiviral drug Therapeutic Indication : Mild to Moderate COVID-19 Dosage Forms : Capsule MORE INFORMATION Keep the medicine out of reach of children Store CIPMOLNU 200 at room temperature